Ono Pharmaceutical
(OTC) OPHLY
Ono Pharmaceutical Financials at a Glance
Market Cap
$7.27B
Revenue (TTM)
$522.75B
Net Income (TTM)
$70.78B
EPS (TTM)
$0.33
P/E Ratio
15.58
Dividend
$0.09
Beta (Volatility)
0.23 (Low)
Dividend
$0.09
Beta (Volatility)
0.23 (Low)
Price
$5.16
Volume
18,366
Open
$5.13
Price
$5.16
Volume
18,366
Open
$5.13
Previous Close
$5.16
Daily Range
$5.13 - $5.16
52-Week Range
$3.35 - $5.75
Dividend
$0.09
Beta (Volatility)
0.23 (Low)
Price
$5.16
Volume
18,366
Open
$5.13
Previous Close
$5.16
Daily Range
$5.13 - $5.16
52-Week Range
$3.35 - $5.75
OPHLY News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Ono Pharmaceutical
Industry
Pharmaceuticals
Sector
Health CareEmployees
4,287
CEO
Gyo Sagara
Website
www.ono-pharma.com/jaHeadquarters
Osaka, 541-8564, JP
OPHLY Financials
Key Financial Metrics (TTM)
Gross Margin
73%
Operating Margin
20%
Net Income Margin
14%
Return on Equity
9%
Return on Capital
11%
Return on Assets
6%
Earnings Yield
6.42%
Dividend Yield
1.66%
Payout Ratio
53.80%
Stock Overview
Market Cap
$7.27B
Shares Outstanding
1.41B
Volume
18.37K
Avg. Volume
30.23K
Financials (TTM)
Gross Profit
$396.63B
Operating Income
$109.57B
EBITDA
$149.60B
Operating Cash Flow
$145.07B
Capital Expenditure
$6.39B
Free Cash Flow
$138.69B
Cash & ST Invst.
$238.13B
Total Debt
$121.46B
Ono Pharmaceutical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$120.93B
+7.7%
Gross Profit
$87.26B
+30.1%
Gross Margin
72.16%
N/A
Market Cap
$7.27B
N/A
Market Cap/Employee
$1.89M
N/A
Employees
3,853
N/A
Net Income
$833.03M
+112.7%
EBITDA
$22.42B
+487.4%
Quarterly Fundamentals
Net Cash
$116.67B
+83.2%
Accounts Receivable
$146.57B
+8.6%
Inventory
$57.70B
-22.9%
Long Term Debt
$82.83B
-27.0%
Short Term Debt
$38.63B
+16.4%
Return on Assets
6.31%
N/A
Return on Invested Capital
10.96%
N/A
Free Cash Flow
$49.80B
+32.5%
Operating Cash Flow
$50.81B
+30.3%